| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199555 | Journal of Allergy and Clinical Immunology | 2010 | 14 Pages |
Abstract
Reduction in nasal symptom scores occurred when the basophil, but not mast cell, response was reduced on omalizumab, implicating a role for basophils in the acute NAC response.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
John A. MD, Patricia M. MS, Denise RN, BSN, Val BS, Mark C. MD, Bruce S. MD, Donald W. MD, PhD, Sarbjit S. MD,